S
Sheela A. Abraham
Researcher at University of Glasgow
Publications - 31
Citations - 1852
Sheela A. Abraham is an academic researcher from University of Glasgow. The author has contributed to research in topics: Stem cell & Liposome. The author has an hindex of 18, co-authored 31 publications receiving 1643 citations. Previous affiliations of Sheela A. Abraham include Uppsala University & Princeton University.
Papers
More filters
Book ChapterDOI
The liposomal formulation of doxorubicin.
Sheela A. Abraham,Dawn Waterhouse,Lawrence D. Mayer,Pieter R. Cullis,Thomas D. Madden,Marcel B. Bally +5 more
TL;DR: This chapter will discuss the various methods for encapsulation of doxorubicin into liposomes, as well as some of the important interactions between the formulation components of the drug and how this may impact the biological activity of the associated drug.
Journal ArticleDOI
In vivo monitoring of tissue pharmacokinetics of liposome/drug using MRI: Illustration of targeted delivery
Benjamin L. Viglianti,Sheela A. Abraham,Sheela A. Abraham,Charles R. Michelich,Pavel S. Yarmolenko,James R. MacFall,Marcel B. Bally,Marcel B. Bally,Mark W. Dewhirst +8 more
TL;DR: The purpose of this study was to determine if MnSO4/doxorubicin (DOX) loaded liposomes could be used for in vivo monitoring of liposome concentration distribution and drug release using MRI, and in vitro results show that T1 shortening correlates with MnSO 4 concentration.
Journal ArticleDOI
Dual targeting of p53 and c-MYC selectively eliminates leukaemic stem cells
Sheela A. Abraham,Lisa E. M. Hopcroft,Emma Carrick,Mark E. Drotar,Karen Dunn,Andrew J.K. Williamson,Koorosh Korfi,Pablo Baquero,Laura Park,Mary T. Scott,Francesca Pellicano,Andrew Pierce,Mhairi Copland,Craig Nourse,Sean M. Grimmond,David Vetrie,Anthony D. Whetton,Tessa L. Holyoake +17 more
TL;DR: Perturbation of both p53 and c-Myc, not BCR-ABL1 itself, leads to synergistic kill, differentiation and near elimination of transplantable human LSC in mice, whilst sparing normal HSC.
Journal ArticleDOI
Formation of transition metal-doxorubicin complexes inside liposomes.
Sheela A. Abraham,Katarina Edwards,Göran Karlsson,Scott E. Macintosh,Lawrence D. Mayer,Lawrence D. Mayer,Cheryl McKenzie,Marcel B. Bally,Marcel B. Bally +8 more
TL;DR: In this paper, doxorubicin complexation with the transition metal manganese (Mn(2+)) has been characterized, differentiating between the formation of a doxbicin-metal complex and doxbricin fibrous bundle aggregates typically generated following ion gradient-based loading procedures that rely on liposome encapsulated citrate or sulfate salts.
Journal ArticleDOI
Encapsulation of doxorubicin into thermosensitive liposomes via complexation with the transition metal manganese.
Gigi N.C. Chiu,Sheela A. Abraham,Ludger M. Ickenstein,Rebecca Ng,Göran Karlsson,Katarina Edwards,Ellen K. Wasan,Marcel B. Bally +7 more
TL;DR: The manganese complexation loading method increased the encapsulation efficiency of doxorubicin in thermosensitive liposomes with no major impact on temperature-triggered drug release or pharmacokinetics.